New Hampshire Code of Administrative Rules
Ph - N.H. Pharmacy Board
Chapter Ph 700 - STANDARDS OF PRACTICE
Part Ph 701 - REFERENCES AND DEFINITIONS
Section Ph 701.02 - Definitions
Current through Register No. 40, October 3, 2024
Except where the context makes another meaning manifest, the following words mean:
(a) "Adulterated drug" means any drug:
(b) "Device" means an instrument, apparatus, implement, machine, contrivance, implant, or other similar or related article, including any component part or accessory, which is required under federal law to bear the label, "Caution: Federal or State law requires dispensing by or on the order of a physician" or "Rx only".
(c) "Distributor" means a person or persons who supplies or facilitates the supply of prescription drugs or devices to someone other than the patient, including, but not limited to, manufacturers, repackagers, brokers and wholesale drug distributors.
(d) "Fit place to practice" means that an employee can safely complete professional and clinical duties and tasks in compliance with the board's rules and statutes because the facility's permit holder has established processes, policies, and procedures necessary to ensure safety.
(e) "Institution" means a health care facility which provides inpatient care and includes:
(f) "Institutional pharmacy" means an area in an institution where drugs are stored, manufactured, compounded, dispensed, or issued to other areas or departments of the institution.
(g) "Misbranded drug" means a drug:
(h) "Permit holder" means a person or entity to whom a license or permit has been issued under the provisions of RSA 318 and RSA 318-B for the purpose of operating a pharmacy.
(i) "Prescriber" means a practitioner, duly authorized by statute, who issues a drug order or prescription.
(j) "Prescription" means a verbal, telephonic, written, or electronically transmitted order for drugs, medicines, and devices by a practitioner licensed in the United States, to be compounded and dispensed by licensed pharmacists in a duly registered pharmacy.
(k) "Principal" means an officer, director, or primary stockholder of a business entity or corporation.
(l) "Professional corporation" as used in these rules means a corporation organized under RSA 294-A for the purpose of providing professional services in the field of medicine, dentistry, veterinary, podiatry, pharmacy, or any other profession in which individual practitioners can lawfully possess, dispense, or distribute prescription drugs.
(m) "Professional judgement" means the application of a combination of professional knowledge and experience to derive a resolution within standards of care, ethics, and objectives.
(n) "Scanned prescription" means the digital image of a prescription or medication order scanned into the data processing system.
(o) "Signature" means:
(p) "Traditional physician-pharmacist-patient relationship" means a situation whereby the pharmacist knows either the physician, the patient, or both, and can readily and easily check on factors concerning the prescription.
(q) "Unit-dose" means a single-unit container that is designed to hold a quantity of drug product intended for administration as a single dose and labeled with the identity, quantity, and strength, name of the manufacturer, lot number, and expiration date of the drug product.
(r) "Unprofessional conduct" means conduct and practices which are hostile to the protection of public health, safety and welfare and includes:
(s) "Wholesale drug distribution" means distribution of prescription drugs other than to the patient, including, but not limited to distribution by manufacturers, repackers, own label distributors, jobbers, and wholesale drug distributors.
#1639, eff 11-1-80; ss by #2260, eff 1-5-83; ss by #2914, eff 11-27-84; ss by #4600, eff 8-1-89; ss by #6094-B, INTERIM, eff 9-21-95, EXPIRED: 1-19-96
New. #6181-B, eff 2-5-96; amd by #6933, eff 2-1-99; amd by #7535, eff 8-1-01; paragraph (a) EXPIRED: 2-5-04; amd by #8316, eff 3-26-05; amd by #8572, eff 2-23-06